Jinxin Fertility Group Limited (abbreviated as JXR) reported no changes in its authorised or issued share capital for the month ended 31 May 2026, according to its latest monthly return filed with Hong Kong Exchanges and Clearing Limited.
At month-end, authorised capital stood at 5.00 billion ordinary shares with a par value of USD 0.00001 each, equivalent to USD 50,000 in total. Issued shares (excluding treasury stock) were unchanged at 2.71 billion, and the company held no treasury shares. Management confirmed that the public-float level remained above the Main Board’s minimum 25 percent requirement.
Although there were no new share issues, option exercises, warrant conversions or transfers from treasury during May, the filing highlights a cumulative repurchase of 46.95 million shares between 27 March and 29 May 2026. These shares are earmarked for cancellation but had not been cancelled as of 31 May.
The board also reiterated that up to 140.84 million ordinary shares are reserved under the 2025 Share Scheme, approved on 5 December 2025, yet no shares were issued under this mandate in May.
Overall, JXR’s equity structure remained stable through the month, while previously repurchased shares are expected to reduce the outstanding share count once formal cancellation is completed.
Comments